A Single Dose Of Psilocybin Can Lead To ‘Rapid’ And ‘Long-Lasting’ Improvements In Depression, Study Indicates

May 26, 2026 by marijuanamoment.net

A Single Dose Of Psilocybin Can Lead To ‘Rapid’ And ‘Long-Lasting’ Improvements In Depression, Study Indicates

Clinical research into psilocybin-assisted therapy is adding to growing interest in psychedelic compounds as potential treatments for depression. A recent randomised trial found that a single dose of psilocybin, combined with psychotherapy, was associated with rapid improvements in depressive symptoms, with some effects lasting for several months. Researchers note, however, that the long-term benefits remain uncertain and that repeated or maintenance treatment may be needed to prevent relapse. The findings contribute to broader scientific debate over how psychedelic therapies should be studied, regulated, and integrated into mental health care.


World map

Categories:


TOP NEWS by REGION

July 27, 2023, 1:04 p.m. by news-medical.net

Tobacco dependence more likely in cigarette smokers, study reveals

Regions: Global

July 28, 2023, 11:16 a.m. by linkedin.com

Forecasting Nicotine Pouches Market till 2023-2030

Regions: Global

July 30, 2023, 11:33 p.m. by regulatorwatch.com

Vital Warning | WHO Is Coming for Your Vapes at COP10 | RegWatch

Regions: Global

July 30, 2023, 8:51 p.m. by colinmendelsohn.com.au

Stop Smoking Start Vaping e-book now free

Regions: Global

Aug. 8, 2023, 9:45 a.m. by insidesources.com

WHO Has Changed Course on Harm Reduction Before; It Must Do So Again

Regions: Global